Risa Labs

Risa Labs raises $3.5M Seed funding to accelerate oncology AI deployment in 100 cancer centers

17th April, 2025

Chris Davis

Writer

Risa Labs raises $3.5M Seed funding to accelerate oncology AI deployment in 100 cancer centers

What does Risa Labs do?

Risa Labs develops BOSS, an AI-powered workflow automation platform that streamlines oncology care by deconstructing complex workflows into micro-tasks and delegating them to a network of intelligent agents such as LLMs, digital twins, and reinforcement learners.

How much did they raise?

The company secured $3.5M in a Seed round, led by Binny Bansal with participation from Oncology Ventures, General Catalyst, z21 Ventures, ODD BIRD VC, and Ashish Gupta.

What are their plans for the money?

The funds will be used to accelerate deployments of the BOSS platform in the next 100 cancer centers over the following two years, potentially revolutionizing oncology workflows and improving patient care.

What have they achieved so far?

Risa Labs has already developed its innovative platform and integrated advanced technologies, establishing a strong foundation for transforming oncology care through automation.

Key Contacts

Kshitij Jaggi
ceo
Kumar Shivang
cto

Company Links

Looking for startup leads?

Every week we source, enrich and send you leads of decision makers from recently funded startups. Sent to you every Monday.

Learn more

Newsletter

Get a daily roundup of recently funded startups.

Recently raised

The latest funding rounds from our newsroom